文献速递肝胆胰外科围术期管理与 ERAS

运动与营养预康复降低肌少症大范围肝切除术后并发症的随机临床试验

Prehabilitation With Exercise and Nutrition to Reduce Morbidity of Major Hepatectomy in Patients With Sarcopenia: The PREHEP Randomized Clinical Trial.
PubMed 文献 · JAMA Surg · 2025-01-01

这项单中心开放标签随机临床试验纳入70例影像学及功能确诊肌少症、拟行大范围肝切除的成人患者,随机接受6周运动联合营养预康复或标准治疗。

要点

  • 肌少症患者大范围肝切除前6周运动联合营养预康复可显著降低90天并发症。
  • 预康复组总体并发症13.3%,对照组50%,绝对风险降低36.7%。
  • 主要并发症仅见于对照组(20%),预康复组肌肉质量与力量显著改善。

核心结论

  • 6周结构化运动联合营养预康复可显著降低肌少症患者大范围肝切除术后的90天并发症。

研究设计与样本

  • 单中心、开放标签、随机临床试验,2022年4月至2025年1月在意大利三级肝胆转诊中心开展。
  • 纳入70例影像学及功能确诊肌少症、拟行大范围肝切除且需未来残肝肥大的成人患者,1:1随机分组,最终分析60例。
  • 干预组接受6周预康复(每日步行、每周两次院内监督运动、支链氨基酸及免疫营养补充),对照组接受标准围术期管理。

主要发现

  • 绝对风险降低36.7%,需治疗人数为3。
  • 肌肉质量与力量仅在预康复组显著改善。

关键数值与推荐

  • 主要结局为采用Clavien-Dindo分级的90天术后并发症。
  • 最终分析60例,中位年龄69岁(IQR 63-75),男性32例(53.3%)。
  • 52例(86.7%)接受门静脉栓塞,63例(88.3%)接受右半肝切除。

临床怎么用

  • 对影像学及功能确诊肌少症、拟行大范围肝切除的患者,可考虑整合6周运动联合营养预康复于术前管理。
  • 预康复方案包括每日步行、每周两次院内监督运动及支链氨基酸与免疫营养补充。

局限性

  • 单中心开放标签设计,最终分析样本量60例,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Sarcopenia is an emerging predictor of complications after liver surgery. Strategies to mitigate its impact are crucial to improving postoperative outcomes. OBJECTIVE: To determine whether a 6-week multimodal prehabilitation program combining physical exercise and nutritional support reduces postoperative morbidity in patients with sarcopenia who are undergoing major hepatectomy. DESIGN, SETTING, AND PARTICIPANTS: This study is a single-center, open-label, randomized clinical trial conducted from April 2022 to January 2025. Adult patients with sarcopenia scheduled for major liver resection and requiring future liver remnant hypertrophy were randomized (1:1) to receive either structured prehabilitation or standard care. The trial was conducted in a tertiary hepatobiliary referral center in Italy. Enrolled adult patients had radiologically and functionally confirmed sarcopenia. Most patients underwent portal vein embolization and right hepatectomy. INTERVENTIONS: The intervention group received a 6-week program while awaiting future liver remnant hypertrophy including daily walking, supervised biweekly in-hospital exercise, and branched-chain amino acid and immune nutritional supplementation. The control group received standard perioperative care. MAIN OUTCOMES AND MEASURES: The primary outcome was 90-day postoperative morbidity, assessed by Clavien-Dindo classification. RESULTS: A total of 70 adult patients with radiologically and functionally confirmed sarcopenia were enrolled, and 60 (median [IQR] age, 69 [63-75] years; 32 male [53.3%]) were included in the final analysis. Most patients (52 [86.7%]) underwent portal vein embolization, and 63 (88.3%) underwent right hepatectomy. Overall morbidity was significantly lower in the prehabilitation group (4 of 30 [13.3%] vs 15 of 30 [50%]; odds ratio, 0.15; 95% CI, 0.04-0.55; P = .004), with an absolute risk reduction of 36.7% and number needed to treat of 3. All major complications occurred in the control group (6 of 30 [20%]; d = 0.40; P = .02). Muscle mass and strength improved significantly only in the prehabilitation arm. CONCLUSIONS AND RELEVANCE: Results of this randomized clinical trial reveal that a 6-week structured prehabilitation program significantly reduced postoperative morbidity in patients with sarcopenia undergoing major liver resection. These findings support integrating exercise and nutritional interventions into preoperative care for high-risk surgical patients to improve surgical outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05281211.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Berardi G, Cucchetti A, Colasanti M, et al. Prehabilitation With Exercise and Nutrition to Reduce Morbidity of Major Hepatectomy in Patients With Sarcopenia: The PREHEP Randomized Clinical Trial. JAMA Surg. 2025. PMID: 40864449. doi:10.1001/jamasurg.2025.3102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。